Literature DB >> 25744101

ERBB4 polymorphism and family history of psychiatric disorders on age-related cortical changes in healthy children.

Vanessa Douet1, Linda Chang, Kristin Lee, Thomas Ernst.   

Abstract

Genetic variations in ERBB4 were associated with increased susceptibility for schizophrenia (SCZ) and bipolar disorders (BPD). Structural imaging studies showed cortical abnormalities in adolescents and adults with SCZ or BPD. However, less is known about subclinical cortical changes or the influence of ERBB4 on cortical development. 971 healthy children (ages 3-20 years old; 462 girls and 509 boys) were genotyped for the ERBB4-rs7598440 variants, had structural MRI, and cognitive evaluation (NIH Toolbox ®). We investigated the effects of ERBB4 variants and family history of SCZ and/or BPD (FH) on cortical measures and cognitive performances across ages 3-20 years using a general additive model. Variations in ERBB4 and FH impact differentially the age-related cortical changes in regions often affected by SCZ and BPD. The ERBB4-TT-risk genotype children with no FH had subtle cortical changes across the age span, primarily located in the left temporal lobe and superior parietal cortex. In contrast, the TT-risk genotype children with FH had more pronounced age-related changes, mainly in the frontal lobes compared to the non-risk genotype children. Interactive effects of age, FH and ERBB4 variations were also found on episodic memory and working memory, which are often impaired in SCZ and BPD. Healthy children carrying the risk-genotype in ERBB4 and/or with FH had cortical measures resembling those reported in SCZ or BPD. These subclinical cortical variations may provide early indicators for increased risk of psychiatric disorders and improve our understanding of the effect of the NRG1-ERBB4 pathway on brain development.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25744101      PMCID: PMC4383396          DOI: 10.1007/s11682-015-9363-y

Source DB:  PubMed          Journal:  Brain Imaging Behav        ISSN: 1931-7557            Impact factor:   3.978


  79 in total

1.  How can we learn about developmental processes from cross-sectional studies, or can we?

Authors:  H C Kraemer; J A Yesavage; J L Taylor; D Kupfer
Journal:  Am J Psychiatry       Date:  2000-02       Impact factor: 18.112

2.  Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls.

Authors:  Kristin K Nicodemus; Amanda J Law; Eugenia Radulescu; Augustin Luna; Bhaskar Kolachana; Radhakrishna Vakkalanka; Dan Rujescu; Ina Giegling; Richard E Straub; Kate McGee; Bert Gold; Michael Dean; Pierandrea Muglia; Joseph H Callicott; Hao-Yang Tan; Daniel R Weinberger
Journal:  Arch Gen Psychiatry       Date:  2010-10

3.  Disordered corticolimbic interactions during affective processing in children and adolescents at risk for schizophrenia revealed by functional magnetic resonance imaging and dynamic causal modeling.

Authors:  Vaibhav A Diwadkar; Sunali Wadehra; Patrick Pruitt; Matcheri S Keshavan; Usha Rajan; Caroline Zajac-Benitez; Simon B Eickhoff
Journal:  Arch Gen Psychiatry       Date:  2012-03

4.  Genetic association analysis of ERBB4 polymorphisms with the risk of schizophrenia and SPEM abnormality in a Korean population.

Authors:  Joon Seol Bae; Charisse Flerida A Pasaje; Byung-Lae Park; Hyun Sub Cheong; Jeong-Hyun Kim; Jason Yongha Kim; Joong-Gon Shin; Chul Soo Park; Bong-Jo Kim; Cheol-Soon Lee; Migyung Lee; Woo Hyuk Choi; Tae-Min Shin; Jaewook Hwang; Hyoung Doo Shin; Sung-Il Woo
Journal:  Brain Res       Date:  2012-05-23       Impact factor: 3.252

5.  Neuroanatomical assessment of biological maturity.

Authors:  Timothy T Brown; Joshua M Kuperman; Yoonho Chung; Matthew Erhart; Connor McCabe; Donald J Hagler; Vijay K Venkatraman; Natacha Akshoomoff; David G Amaral; Cinnamon S Bloss; B J Casey; Linda Chang; Thomas M Ernst; Jean A Frazier; Jeffrey R Gruen; Walter E Kaufmann; Tal Kenet; David N Kennedy; Sarah S Murray; Elizabeth R Sowell; Terry L Jernigan; Anders M Dale
Journal:  Curr Biol       Date:  2012-08-16       Impact factor: 10.834

6.  Cognition assessment using the NIH Toolbox.

Authors:  Sandra Weintraub; Sureyya S Dikmen; Robert K Heaton; David S Tulsky; Philip D Zelazo; Patricia J Bauer; Noelle E Carlozzi; Jerry Slotkin; David Blitz; Kathleen Wallner-Allen; Nathan A Fox; Jennifer L Beaumont; Dan Mungas; Cindy J Nowinski; Jennifer Richler; Joanne A Deocampo; Jacob E Anderson; Jennifer J Manly; Beth Borosh; Richard Havlik; Kevin Conway; Emmeline Edwards; Lisa Freund; Jonathan W King; Claudia Moy; Ellen Witt; Richard C Gershon
Journal:  Neurology       Date:  2013-03-12       Impact factor: 9.910

Review 7.  Executive function, neural circuitry, and genetic mechanisms in schizophrenia.

Authors:  Daniel Paul Eisenberg; Karen Faith Berman
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

Review 8.  Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence.

Authors:  P J Harrison; D R Weinberger
Journal:  Mol Psychiatry       Date:  2005-01       Impact factor: 15.992

Review 9.  Reconciling neuroimaging and neuropathological findings in schizophrenia and bipolar disorder.

Authors:  Alex Fornito; Murat Yücel; Christos Pantelis
Journal:  Curr Opin Psychiatry       Date:  2009-05       Impact factor: 4.741

10.  Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia.

Authors:  Nadine Norton; Valentina Moskvina; Derek W Morris; Nicholas J Bray; Stanley Zammit; Nigel M Williams; Hywel J Williams; Anna C Preece; Sarah Dwyer; Jennifer C Wilkinson; Gillian Spurlock; George Kirov; Paul Buckland; John L Waddington; Michael Gill; Aiden P Corvin; Michael J Owen; Michael C O'Donovan
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-01-05       Impact factor: 3.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.